Prevalence of the metabolic syndrome in patients with borderline personality disorder: Results from a cross-sectional study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 263, Issue 3, 2013, Pages 205-213

  Kahl, Kai G ^a   Greggersen, Wiebke ^b   Schweiger, Ulrich ^b   Cordes, Joachim ^c   Correll, Christoph U ^d,e   Frieling, Helge ^a   Balijepalli, Chakrapani ^f   Lösch, Christian ^f   Moebus, Susanne ^f  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Luebeck Medical School   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Borderline personality disorder; Depressive disorder; Diabetes mellitus; Metabolic syndrome; Second generation antipsychotics

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZIPRASIDONE;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BINGE EATING DISORDER; BODY MASS; BODY WEIGHT; BORDERLINE STATE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPENDENT PERSONALITY DISORDER; DIET RESTRICTION; DISEASE ASSOCIATION; DSM-IV; DYSTHYMIA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MENTAL PATIENT; METABOLIC SYNDROME X; NATIONAL HEALTH ORGANIZATION; PANIC; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; ANTHROPOMETRY; BORDERLINE PERSONALITY DISORDER; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GERMANY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84879462008     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-012-0339-2     Document Type: Article

References (54)

1. Boehm G, Racoosin JA, Laughren TP, Katz R (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27:596-601
2. Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM, Cornell C, Saab PG, Kaufmann PG, Czajkowski SM, Jaffe AS (2004) Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosom Med 66:466-474 (Pubitemid 38971239)
3. Cooper SJ (2005) Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes. Appetite 44:133-150 (Pubitemid 40461672)
4. Cuppett M, Latin RW (2002) A survey of physical activity levels of certified athletic trainers. J Athl Train 37:281-285
5. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European psychiatric association (EPA), supported by the European association for the study of diabetes (EASD) and the European society of cardiology (ESC). Eur Psychiatry 24:412-424
6. De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, Newcomer JW, Uwakwe R, Asai I, Moller HJ, Gautam S, Detraux J, Correll CU (2011) Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 10:138-151
7. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU (2011) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8:114-126
8. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Moller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10:52-77
9. de Jonge P, Honig A, van Melle JP, Schene AH, Kuyper AM, Tulner D, Schins A, Ormel J (2007) Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 164:1371-1378 (Pubitemid 47461137)
10. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 375:181-183
11. El-Gabalawy R, Katz LY, Sareen J (2010) Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom Med
12. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ (2005) Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for pennsylvanians. Bipolar Disord 7:424-430 (Pubitemid 41419409)
13. Fogelholm M (2010) Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review. Obes Rev 11:202-221
14. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 287:356-359 (Pubitemid 34251969)
15. Frankenburg FR, Zanarini MC (2004) The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 65:1660-1665
16. Friedman M, Rosenman RH (1959) Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. J Am Med Assoc 169:1286-1296
17. Glassman AH, Bigger JT Jr, Gaffney M (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 66:1022-1029
18. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP (2004) Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 65:948-958
19. Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ (2008) Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 69:533-545 (Pubitemid 351792327)
20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752 (Pubitemid 41532612)
21. Haney M, Comer SD, Fischman MW, Foltin RW (1997) Alprazolam increases food intake in humans. Psychopharmacology (Berl) 132:311-314 (Pubitemid 27351433)
22. Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M (2006) Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom Med 68:213-216 (Pubitemid 43740123)
23. Hudson JI, Lalonde JK, Coit CE, Tsuang MT, McElroy SL, Crow SJ, Bulik CM, Hudson MS, Yanovski JA, Rosenthal NR, Pope HG Jr (2010) Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. Am J Clin Nutr 91:1568-1573
24. Hybels CF, Pieper CF, Blazer DG, Steffens DC (2008) The course of depressive symptoms in older adults with comorbid major depression and dysthymia. Am J Geriatr Psychiatry 16:300-309
25. Jackson HJ, Burgess PM (2004) Personality disorders in the community: results from the Australian National Survey of Mental Health and Well-being Part III. Relationships between specific type of personality disorder, Axis 1 mental disorders and physical conditions with disability and health consultations. Soc Psychiatry Psychiatr Epidemiol 39:765-776 (Pubitemid 39377812)
26. Kahl KG, Bester M, Greggersen W, Rudolf S, Dibbelt L, Stoeckelhuber BM, Gehl HB, Sipos V, Hohagen F, Schweiger U (2005) Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom Med 67:407-412 (Pubitemid 40727153)
27. Kahl KG, Bens S, Ziegler K, Rudolf S, Dibbelt L, Kordon A, Schweiger U (2006) Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biol Psychiatry 59:667-671 (Pubitemid 43357963)
28. Kahl KG, Bens S, Ziegler K, Rudolf S, Kordon A, Dibbelt L, Schweiger U (2009) Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinology 34:353-357
29. Kahl KG, Greggersen W, Schweiger U, Cordes J, Balijepalli C, Losch C, Moebus S (2011) Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci [epub ahead of print]
30. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617-627 (Pubitemid 40973437)
31. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP (2004) Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 66:316-322 (Pubitemid 38668398)
32. Lee HB, Bienvenu OJ, Cho SJ, Ramsey CM, Bandeen-Roche K, Eaton WW, Nestadt G (2010) Personality disorders and traits as predictors of incident cardiovascular disease: findings from the 23-year follow-up of the Baltimore ECA study. Psychosomatics 51:289-296
33. Lieb K, Rexhausen JE, Kahl KG, Schweiger U, Philipsen A, Hellhammer DH, Bohus M (2004) Increased diurnal salivary cortisol in women with borderline personality disorder. J Psychiatr Res 38:559-565 (Pubitemid 39348887)
34. Martinez JM, Garakani A, Kaufmann H, Aaronson CJ, Gorman JM (2010) Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients. Psychosom Med 72:442-449
35. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M (2011) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr Bull [epub ahead of print]
36. Moebus S, Hanisch JU, Neuhauser M, Aidelsburger P, Wasem J, Jockel KH (2006) Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices. Ger Med Sci 4:Doc07
37. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jockel KH (2007) Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 6:22 (Pubitemid 47616464)
38. Moran P, Stewart R, Brugha T, Bebbington P, Bhugra D, Jenkins R, Coid JW (2007) Personality disorder and cardiovascular disease: results from a national household survey. J Clin Psychiatry 68:69-74 (Pubitemid 46220126)
39. Nabi H, Kivimaki M, Zins M, Elovainio M, Consoli SM, Cordier S, Ducimetiere P, Goldberg M, Singh-Manoux A (2008) Does personality predict mortality? Results from the GAZEL French prospective cohort study. Int J Epidemiol 37:386-396 (Pubitemid 351494217)
40. Nakashita Y, Nakamura M, Kitamura A, Kiyama M, Ishikawa Y, Mikami H (2010) Relationships of cigarette smoking and alcohol consumption to metabolic syndrome in Japanese men. J Epidemiol 20:391-397
41. Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roque IFM, Richter B, Mauricio D (2008) Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev CD003054
42. Patel JK, Buckley PF, Woolson S, Hamer RM, McEvoy JP, Perkins DO, Lieberman JA, Investigators C (2009) Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res 111:9-16
43. Pfaltz MC, Grossman P, Michael T, Margraf J, Wilhelm FH (2010) Physical activity and respiratory behavior in daily life of patients with panic disorder and healthy controls. Int J Psychophysiol 78:42-49
44. Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, Brunzell JD (2009) Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab 296:E351-E357
45. Rafanelli C, Milaneschi Y, Roncuzzi R, Pancaldi LG (2010) Dysthymia before myocardial infarction as a cardiac risk factor at 2.5-year follow-up. Psychosomatics 51:8-13
46. Raikkonen K, Matthews KA, Kuller LH (2002) The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 51:1573-1577 (Pubitemid 36018831)
47. Richter N, Juckel G, Assion HJ (2010) Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci 260:41-49
48. Schweiger U, Greggersen W, Rudolf S, Pusch M, Menzel T, Winn S, Hassfurth J, Fassbinder E, Kahl KG, Oltmanns KM, Hohagen F, Peters A (2008) Disturbed glucose disposal in patients with major depression; application of the glucose clamp technique. Psychosom Med 70:170-176 (Pubitemid 351252964)
49. Shaw K, Gennat H, O'Rourke P, Del Mar C (2006) Exercise for overweight or obesity. Cochrane Database Syst Rev CD003817
50. Simon V, van Winkel R, De Hert M (2009) Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. J Clin Psychiatry 70:1041-1050
51. Skilton MR, Moulin P, Terra JL, Bonnet F (2007) Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 62:1251-1257 (Pubitemid 350060887)
52. Skodol AE, Grilo CM, Pagano ME, Bender DS, Gunderson JG, Shea MT, Yen S, Zanarini MC, McGlashan TH (2005) Effects of personality disorders on functioning and well-being in major depressive disorder. J Psychiatr Pract 11:363-368 (Pubitemid 41690415)
53. Skodol AE, Pagano ME, Bender DS, Shea MT, Gunderson JG, Yen S, Stout RL, Morey LC, Sanislow CA, Grilo CM, Zanarini MC, McGlashan TH (2005) Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychol Med 35:443-451 (Pubitemid 40372482)
54. Vancampfort D, De Hert M, Skjerven LH, Gyllensten AL, Parker A, Mulders N, Nyboe L, Spencer F, Probst M (2012) International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia. Disabil Rehabil 34:1-12